Discover how Verve Therapeutics’ new patent for gene editing targeting the PCSK9 gene could revolutionize LDL cholesterol treatment and combat cardiovascular disease.
Livanova names J&J veteran Vladimir Makatsaria as CEO
Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Name: Vladimir Makatsaria New title: CEO, Livanova